Skip to content

Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study

Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02564731
Enrollment
300
Registered
2015-10-01
Start date
2016-06-30
Completion date
2022-03-31
Last updated
2017-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Keywords

children, prognosis

Brief summary

This prospective cohort study is designed to observe of the effect of intervention therapy on the long-term prognosis of children with bronchiectasis. The main purpose of the study was to evaluate the degree of deterioration of lung function, to observe and compare the quality of life, the time of pulmonary exacerbation, and the changes of lung image.

Detailed description

All enrolled patients are followed up for half a year, 1 years, 2 years, 3 years, 4 years, 5 years, while observation of pulmonary function, symptoms, signs, quality of life, the times of acute pulmonary exacerbation, and the changes of lung image are performed.

Interventions

None listed

Sponsors

Wuhan women and children's health care center
CollaboratorUNKNOWN
Children's Hospital of Chongqing Medical University
CollaboratorOTHER
Yuying Children's Hospital of Wenzhou Medical University
CollaboratorOTHER
Changchun Children's Hospital
CollaboratorOTHER
Shenzhen Children's Hospital
CollaboratorOTHER_GOV
Jiangxi Province Children's Hospital
CollaboratorOTHER
Shanghai Children's Medical Center
CollaboratorOTHER
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
Tianjin Children's Hospital
CollaboratorOTHER
The First Affiliated Hospital of Xiamen University
CollaboratorOTHER
Children's Hospital of Fudan University
CollaboratorOTHER
The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Shanxi Provincial Maternity and Children's Hospital
CollaboratorOTHER
Baoping XU
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

A included patient must be coincident at least one point of the four items of high-resolution computed tomography (HRCT) manifestations. * Internal bronchial diameter greater than the accompanying pulmonary artery. * lack of bronchial tapering * bronchi visible in the peripheral 1cm of lung * bronchial diameter greater than adjacent segmental bronchi

Exclusion criteria

Subject will be excluded if she or he has one of the following * It is unable or doesn't agree to accept the follow-up process * undergoing trial for other medications or instruments.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in lung function on the spirometry5 yearsforced expiratory volume at one second (FEV1) in Liter

Countries

China

Contacts

Primary ContactBaoping Xu, MD,PhD
xubaopingbch@163.com861059616308

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026